LV12806B - Cc-1065 analogi ar divam cpi apaksvienibam - Google Patents

Cc-1065 analogi ar divam cpi apaksvienibam

Info

Publication number
LV12806B
LV12806B LV010180A LV010180A LV12806B LV 12806 B LV12806 B LV 12806B LV 010180 A LV010180 A LV 010180A LV 010180 A LV010180 A LV 010180A LV 12806 B LV12806 B LV 12806B
Authority
LV
Latvia
Prior art keywords
pct
formula
date mar
compounds
sec
Prior art date
Application number
LV010180A
Other languages
English (en)
Latvian (lv)
Other versions
LV12806A (en
Inventor
Robert C Kelly
Paul A Aristoff
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of LV12806A publication Critical patent/LV12806A/en
Publication of LV12806B publication Critical patent/LV12806B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Error Detection And Correction (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Amplifiers (AREA)
  • Solid State Image Pick-Up Elements (AREA)
  • Semiconductor Integrated Circuits (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Television Receiver Circuits (AREA)
  • Stereophonic System (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Television Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
LV010180A 1988-09-12 2001-12-27 Cc-1065 analogi ar divam cpi apaksvienibam LV12806B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24335088A 1988-09-12 1988-09-12
PCT/US1989/003329 WO1990002746A1 (en) 1988-09-12 1989-08-07 Novel cc-1065 analogs having two cpi subunits

Publications (2)

Publication Number Publication Date
LV12806A LV12806A (en) 2002-03-20
LV12806B true LV12806B (lv) 2002-05-20

Family

ID=22918400

Family Applications (1)

Application Number Title Priority Date Filing Date
LV010180A LV12806B (lv) 1988-09-12 2001-12-27 Cc-1065 analogi ar divam cpi apaksvienibam

Country Status (14)

Country Link
US (1) US5541339A (da)
JP (1) JP3380237B2 (da)
KR (1) KR0137959B1 (da)
AT (1) ATE198335T1 (da)
AU (1) AU632288B2 (da)
CA (1) CA1340215C (da)
DE (1) DE68929275T2 (da)
DK (1) DK175458B1 (da)
FI (1) FI103668B1 (da)
GR (1) GR3035589T3 (da)
LV (1) LV12806B (da)
NO (1) NO303498B1 (da)
TW (1) TW217383B (da)
WO (1) WO1990002746A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69231123T2 (de) * 1992-03-25 2001-02-15 Immunogen Inc Konjugaten von Zell-bindender Mittel und Derivaten von CC-1065
US5502068A (en) * 1995-01-31 1996-03-26 Synphar Laboratories, Inc. Cyclopropylpyrroloindole-oligopeptide anticancer agents
EP2163256B1 (en) 2001-05-11 2015-09-02 Ludwig Institute for Cancer Research Ltd. Specific binding proteins and uses thereof
US20100056762A1 (en) 2001-05-11 2010-03-04 Old Lloyd J Specific binding proteins and uses thereof
YU37904A (sh) 2001-11-09 2006-08-17 Boehringer Ingelheim Pharmaceuticals Inc. Benzimidazoli kao korisni inhibitori proteinske kinaze
AU2003257094A1 (en) * 2002-08-08 2004-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted benzimidazole compounds
US20050215614A1 (en) * 2002-10-15 2005-09-29 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
CA2531485C (en) * 2003-07-07 2013-03-26 Merck Patent Gmbh Malonamide derivatives
WO2005079791A1 (en) * 2004-02-12 2005-09-01 Boehringer Ingelheim Pharmaceuticals, Inc. Thiophene -2- carboxylic acid - (1h - benzimidazol - 2 yl) - amide derivatives and related compounds as inhibitors of the tec kinase itk (interleukin -2- inducible t cell kinase) for the treatment of inflammation, immunological and allergic disorders
JP2009504756A (ja) * 2005-08-17 2009-02-05 シェーリング コーポレイション 新規な高親和性のチオフェンベースおよびフランベースのキナーゼリガンド
CN101711284A (zh) 2007-01-25 2010-05-19 达娜-法勃肿瘤研究所 抗egfr抗体在治疗egfr突变体介导的疾病中的用途
CN101688229B (zh) 2007-03-15 2013-06-12 路德维格癌症研究所 包含egfr抗体和src抑制剂的组合物及其在制备用于治疗哺乳动物癌症的药物中的用途
US9901567B2 (en) 2007-08-01 2018-02-27 Syntarga B.V. Substituted CC-1065 analogs and their conjugates
CN108424454B (zh) 2007-08-14 2022-05-31 路德维格癌症研究所有限公司 靶向egf受体的单克隆抗体175及其衍生物和用途
NO2344478T3 (da) 2008-11-03 2018-02-24
ES2815678T3 (es) 2010-04-21 2021-03-30 Syntarga Bv Conjugados de análogos de CC-1065 y conectores bifuncionales
EP2908809A2 (en) 2012-10-22 2015-08-26 Arnold Glazier Methods for the effective treatment of metastatic cancer
DE102013012622A1 (de) * 2013-07-30 2015-02-05 Clariant lnternational Ltd Neue sterisch gehinderte cyclische Amine
CA2935456C (en) 2014-01-10 2018-09-18 Synthon Biopharmaceuticals B.V. Method for purifying cys-linked antibody-drug conjugates
SG11201605437YA (en) * 2014-01-27 2016-08-30 Pfizer Bifunctional cytotoxic agents
EP3160513B1 (en) 2014-06-30 2020-02-12 Glykos Finland Oy Saccharide derivative of a toxic payload and antibody conjugates thereof
DE102015000124A1 (de) * 2015-01-07 2016-07-07 Clariant International Ltd. Verfahren zur Stabilisierung von Polyamiden
CA2923862C (en) * 2015-03-20 2024-02-13 Pfizer Inc. Bifunctional cytotoxic agents containing the cti pharmacophore

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169888A (en) * 1977-10-17 1979-10-02 The Upjohn Company Composition of matter and process
US4301248A (en) * 1979-12-21 1981-11-17 Bristol-Myers Company Fermentation process for making rachelmycin
US4413132A (en) * 1980-11-18 1983-11-01 The Upjohn Company Antibiotic CC-1065 indoline intermediates
US4912227A (en) * 1984-02-21 1990-03-27 The Upjohn Company 1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds
CA1238907A (en) * 1984-02-21 1988-07-05 Robert C. Kelly 1,2,8,8a-tetrahydrocyclopropa¬c|pyrrolo(3,2-e)- indol-4(5h)-ones and related compounds
GB8528848D0 (en) * 1985-11-22 1985-12-24 Davy Mckee Poole Rolling mills
AU617304B2 (en) * 1986-12-19 1991-11-28 Pharmacia & Upjohn Company Novel cc-1065 analogs

Also Published As

Publication number Publication date
FI103668B (fi) 1999-08-13
AU632288B2 (en) 1992-12-24
LV12806A (en) 2002-03-20
CA1340215C (en) 1998-12-15
DK41791A (da) 1991-03-08
ATE198335T1 (de) 2001-01-15
JP3380237B2 (ja) 2003-02-24
NO303498B1 (no) 1998-07-20
NO910958L (no) 1991-05-10
US5541339A (en) 1996-07-30
AU4192289A (en) 1990-04-02
FI103668B1 (fi) 1999-08-13
DE68929275T2 (de) 2001-05-23
TW217383B (da) 1993-12-11
KR900701801A (ko) 1990-12-04
DE68929275D1 (de) 2001-02-01
DK41791D0 (da) 1991-03-08
GR3035589T3 (en) 2001-06-29
WO1990002746A1 (en) 1990-03-22
FI911193A0 (fi) 1991-03-11
NO910958D0 (no) 1991-03-11
JPH04500664A (ja) 1992-02-06
KR0137959B1 (ko) 1998-05-15
DK175458B1 (da) 2004-11-01

Similar Documents

Publication Publication Date Title
LV12806B (lv) Cc-1065 analogi ar divam cpi apaksvienibam
ES2082003T3 (es) Deshidrodidemnina b.
DK0631575T3 (da) Substituerede pyrimidiner samt deres anvendelse som fungicider
DK0653439T3 (da) Stabiliserede oligonukleotider og anvendelse heraf
TR200002616T2 (tr) Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
ATE112279T1 (de) Cc-1065 analoge.
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
TR200000152T2 (tr) Yeni bileşikler.
DE3774286D1 (de) (2,2-bis(aminomethyl)-1,3-propandiol-n,n')platin-komplexe.
ES2009720A4 (es) Agentes para tenir los cabellos.
ES2153814T3 (es) Analogos de cc-1065 que tienen dos subunidades cpi.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
WO1987004923A3 (fr) Amides aromatiques absorbant les u.v.
DK178188D0 (da) Antivirusmiddel
ATE86994T1 (de) Ornithin-derivate und deren verwendung als inhibitoren von methothrexat resistenten zellen.
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE51001T1 (de) Koordinationsverbindungen von platin.
PT89742A (pt) Processo de preparacao de 24r-cimnol e de suas composicoes farmaceuticas
ES2060050T3 (es) Beta-tioacrilamidas s-sustituidas y su uso como microbicidas.
NO960271L (no) Tiokarbamoylforbindelser anvendt som mikrobiocider
DE3768322D1 (de) Substituierte alkynische thiocyanate, sie enthaltende biozide zusammensetzungen und deren verwendung.
ES2126015T3 (es) Uso de etofibrato y composiciones farmaceuticas que contienen etofibrato para el tratamiento de la angiopatia y la retinopatia diabeticas.
DE69909010D1 (de) Verwendung von procyanidolischen Oligomeren oder Anthocyanosiden als Anti-Urease Wirkstoffe
ES2052499T3 (es) Complejos de (gem-heterociclodimenatamina-n,n') platino.